Startups
The FDA has issued an Emergency Use Authorization (EUA) for the product sotrovimab. Find EUA Fact Sheets, FDA Letter of Authorization, and more.
Overview
Employees
11-50
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 24, 2022 | How can I get Paxlovid, the COVID-19 pill? Access to COVID treatments remains a challenge | Despite evidence showing the fast-spreading Omicron variant may pose a smaller risk of severe COVID-19 compared to the Delta variant, public health officials have warned for months that millions of Americans remain at high risk of severe il... |
| Jun 21, 2021 | GLAXOSMITHKLINE PLC GlaxoSmithKline : GSK and Vir Biotechnology announce continuing progress of the COMET clinical development programme for sotrovimab | For media and investors only Issued: London, UK Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalisation and risk of death in adults with mild-to-moderate COVID-19 who are at high risk of progre... |
Reviews 0
FAQ about Sotrovimab
What has the press written about Sotrovimab?
Parsers VC has collected 3 articles mentioning Sotrovimab, among them “How can I get Paxlovid, the COVID-19 pill? Access to COVID treatments remains a challenge” (Jan 24, 2022) and “GLAXOSMITHKLINE PLC GlaxoSmithKline : GSK and Vir Biotechnology announce continuing progress of the COMET clinical development programme for sotrovimab” (Jun 21, 2021).
Is Sotrovimab still active?
Yes, Sotrovimab is active; its latest activity on Parsers VC dates from Apr 8, 2022.